Pharmaceutical & Biotechnology
Alnylam Pharmaceuticals
About this employer
Alnylam Pharmaceuticals is a biopharmaceutical company founded in Cambridge, MA in 2002 that develops RNA interference (RNAi) therapeutics, medicines that silence genes causing disease. It has six approved RNAi medicines, including ONPATTRO, GIVLAARI, OXLUMO and AMVUTTRA, targeting rare and prevalent diseases such as amyloidosis, and manufactures in Norton, MA.
Roles they hire for
Explore this area
Browse more healthcare employers in Cambridge or Massachusetts.